“23. SYSTEMATIC REVIEW OF THE COST - EFFECTIVENESS OF PEMBROLIZUMAB IN RECURRENT OR METASTATIC CERVICAL CANCER” (2025) Vietnam Journal of Community Medicine, 66(CĐ8-NCKH). doi:10.52163/yhc.v66iCD8.2569.